| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |